Abstract
Mutations in the tumor suppressor BRCA2 predominantly predispose to breast cancer. Paradoxically, while loss of BRCA2 promotes tumor formation, it also causes cell lethality, although how lethality is triggered is unclear. Here, we generate BRCA2 conditional non-transformed human mammary epithelial cell lines using CRISPR-Cas9. Cells are inviable upon BRCA2 loss, which leads to replication stress associated with under replication, causing mitotic abnormalities, 53BP1 nuclear body formation in the ensuing G1 phase, and G1 arrest. Unexpected from other systems, the role of BRCA2 in homologous recombination, but not in stalled replication fork protection, is primarily associated with supporting human mammary epithelial cell viability, and, moreover, preventing replication stress, a hallmark of pre-cancerous lesions. Thus, we uncover a DNA under replication-53BP1 nuclear body formation-G1 arrest axis as an unanticipated outcome of homologous recombination deficiency, which triggers cell lethality and, we propose, serves as a barrier that must be overcome for tumor formation.
Highlights
Mutations in the tumor suppressor BRCA2 predominantly predispose to breast cancer
Exons 3 and 4 encode residues that are essential for PALB2 binding[17], which is required for mouse embryonic stem cell viability[18]
Using a BRCA2 conditional system in a non-transformed human mammary epithelial cell line, we show that BRCA2 deficiency induces replication stress, resulting in single-stranded DNA (ssDNA) lesions in G2, failure to complete DNA replication and concomitant 53BP1 nuclear body formation in the subsequent G1 phase, to lead to p53dependent G1 arrest and cellular senescence
Summary
Mutations in the tumor suppressor BRCA2 predominantly predispose to breast cancer. Paradoxically, while loss of BRCA2 promotes tumor formation, it causes cell lethality, how lethality is triggered is unclear. The role of BRCA2 in the protection of stalled replication forks was reported to be sufficient to sustain viability of mouse embryonic stem (ES) cells and to confer resistance of tumor cells to crosslinking agents and PARP inhibitors even in the absence of functional HR8, 9. Viable, these ES cells grow poorly, and fork protection alone is not capable of supporting embryo development[8], suggesting that HR is essential in some contexts. How the two pathways functionally interact to ensure genome integrity and cell viability in adult tissues, such as normal mammary cells to prevent breast cancer initiation remains elusive
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have